Trial: 202004058

A study to assess overall response rate by inducing an inflammatory phenotype in Metastatic BReast cAnCEr with the Oncolytic Reovirus PeLareorEp in CombinaTion with anti-PD-L1 Avelumab and Paclitaxel BRACELET-1 Study

Phase

II

Principal Investigator

Clifton, Katherine

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov